Company Gracell Biotechnologies Inc.
Equities
GRCL
US38406L1035
Biotechnology & Medical Research
Business Summary
Number of employees: 314
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wei Cao
CEO | Chief Executive Officer | 66 | 01/17/01 |
Yi Li Xie
DFI | Director of Finance/CFO | 54 | 24/20/24 |
Wendy Li
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/22/01 |
Gracie Tong
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Cao
CEO | Chief Executive Officer | 66 | 01/17/01 |
Guo Tong Xu
BRD | Director/Board Member | 67 | 01/19/01 |
Guo Wei Wang
BRD | Director/Board Member | 63 | 01/20/01 |
Kin Ping Lee
BRD | Director/Board Member | 54 | 09/21/09 |
Wendy Hayes
BRD | Director/Board Member | 54 | 07/21/07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 61,364,562 | 0 | 0 | 83.58 % |
Stock B | 0 | 59,327,653 | 0 | 0 | |
Stock C | 1 | 479,632,139 | 400,876,542 ( 83.58 %) | 0 | |
Stock D | 0 | 21,735,721 | 0 | 0 | |
Stock E | 0 | 31,343,284 | 0 | 0 |
Company contact information
Gracell Biotechnologies, Inc.
Biobay & Suzhou Industrial Park 218 Sangtian Street
215123, Suzhou
+
http://www.gracellbio.comSector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |